Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-label, Controlled Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

NCT02528318 is registered in ClinicalTrials.gov with Windtree Therapeutics as lead sponsor.

NCT NCT02528318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02528318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-label, Controlled Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
Lead sponsor
Windtree Therapeutics
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2015
Completion date
August 11, 2017
Enrollment
48 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome